Withdrawal of parathyroid hormone treatment causes rapid resorption of newly formed vertebral cancellous and endocortical bone in old rats (Q32054858)

6 July 2017

title

Withdrawal of parathyroid hormone treatment causes rapid resorption of newly formed vertebral cancellous and endocortical bone in old rats (English)

1 reference

6 July 2017

Ejersted C

1

1 reference

6 July 2017

Oxlund H

series ordinal

2

1 reference

6 July 2017

Eriksen EF

series ordinal

3

1 reference

6 July 2017

Andreassen TT

series ordinal

4

1 reference

6 July 2017

publication date

1 July 1998

1 reference

6 July 2017

1 reference

6 July 2017

volume

23

1 reference

6 July 2017

issue

1

1 reference

6 July 2017

page(s)

43-52

1 reference

Growth hormone stimulates bone formation and strength of cortical bone in aged rats

6 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900072-6

7 January 2021

The influence of growth hormone on cancellous and cortical bone of the vertebral body in aged rats.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900072-6

7 January 2021

Tartrate-resistant acid phosphate activity as osteoclastic marker: sensitivity of cytochemical assessment and serum assay in comparison with standardized osteoclast histomorphometry

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900072-6

7 January 2021

Long-term effect of orchidectomy on cortical bone from rat femur: bone mass and mechanical properties

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900072-6

7 January 2021

Parathyroid hormone (1-34) increases vertebral bone mass, compressive strength, and quality in old rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900072-6

7 January 2021

Human parathyroid hormone(1-34) increases bone formation and strength of cortical bone in aged rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900072-6

7 January 2021

Bisphosphonate maintains parathyroid hormone (1-34)-induced cortical bone mass and mechanical strength in old rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900072-6

7 January 2021

Loss of the anabolic effect of parathyroid hormone on bone after discontinuation of hormone in rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900072-6

7 January 2021

Continuous alendronate treatment throughout growth, maturation, and aging in the rat results in increases in bone mass and mechanical properties

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900072-6

7 January 2021

Increase of whole-body calcium and skeletal mass in normal and osteoporotic adult rats treated with parathyroid hormone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900072-6

7 January 2021

Intermittent cyclical etidronate treatment maintains the mass, structure and the mechanical property of bone in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900072-6

7 January 2021

Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900072-6

7 January 2021

Impaired bone activity in aged rats: alterations at the cellular and molecular levels

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900072-6

7 January 2021

Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900072-6

7 January 2021

Sequential effects of chronic human PTH (1-84) treatment of estrogen-deficiency osteopenia in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900072-6

7 January 2021

The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents (estrogen and calcitonin), human parathyroid hormone-(1-38), and combination therapy, assessed in aged ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900072-6

7 January 2021

The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: a comparison study between hPTH-(1-34) and hPTH-(1-84).

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900072-6

7 January 2021

PTH has a more pronounced effect on vertebral bone mass and biomechanical competence than antiresorptive agents (estrogen and bisphosphonate)--assessed in sexually mature, ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900072-6

7 January 2021

No loss of biomechanical effects after withdrawal of short-term PTH treatment in an aged, osteopenic, ovariectomized rat model

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900072-6

7 January 2021

Evidence for a diminished maturation of preosteoblasts into osteoblasts during aging in rats: an ultrastructural analysis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900072-6

7 January 2021

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900072-6

7 January 2021

Effects of reciprocal treatment with estrogen and estrogen plus parathyroid hormone on bone structure and strength in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900072-6

7 January 2021

Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1-34) administration in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900072-6

7 January 2021

Effects of 4-amino-1-hydroxybutylidene bisphosphonate on bone biomechanics in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900072-6

7 January 2021

Time course of vertebral osteopenia in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900072-6

7 January 2021

Skeletal effects of withdrawal of estrogen and diphosphonate treatment in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900072-6

7 January 2021

Maintenance of bone mass by physical exercise after discontinuation of intermittent hPTH(1-34) administration

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900072-6

7 January 2021

10.1016/S8756-3282(98)00072-6

Identifiers

DOI

1 reference

6 July 2017

1 reference